{"filing":{"accession_number":"0001654954-26-007306","cik":"0001684144","ticker":"ZOMDF","company_name":"Zomedica Corp.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"zom_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426007306/zom_8k.htm"},"events":[{"id":25199,"run_id":22864,"accession_number":"0001654954-26-007306","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Zomedica issued a press release on August 5, 2026 announcing consolidated financial results for the three and six months ended June 30, 2026, disclosing record second-quarter revenue of $9.5 million (up 37% year-over-year), net loss reduced 49%, and $44.1 million in liquidity. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event type.","company_name":"Zomedica Corp.","ticker":"ZOMDF","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25959,"accession_number":"0001654954-26-007306","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Zomedica issued a press release on August 5, 2026 announcing consolidated financial results for the three and six months ended June 30, 2026, disclosing record second-quarter revenue of $9.5 million (up 37% year-over-year), net loss reduced 49%, and $44.1 million in liquidity. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:18:31.526322+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25959,"accession_number":"0001654954-26-007306","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Zomedica issued a press release on August 5, 2026 announcing consolidated financial results for the three and six months ended June 30, 2026, disclosing record second-quarter revenue of $9.5 million (up 37% year-over-year), net loss reduced 49%, and $44.1 million in liquidity. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:18:31.526322+00:00","company_name":"Zomedica Corp.","ticker":"ZOMDF","filing_date":"2026-08-05"}]}